AI assistant
Sending…
CONMED Corp — Director's Dealing 2012
Mar 21, 2012
31971_dirs_2012-03-21_7aad4620-8ece-4bc1-a487-ab42fc932475.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-03-20
Reporting Person: SHALLISH ROBERT D JR (Vice President/Finance/CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-03-20 | Common Stock | M | 15000 | $25.89 | Acquired | 44271 | Direct |
| 2012-03-20 | Common Stock | F | 13134 | $29.57 | Disposed | 31137 | Direct |
| 2012-03-20 | Common Stock | F | 409 | $29.57 | Disposed | 30728 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-20 | Options To Purchase Common Stock | $25.89 | M | 15000 | Disposed | 2012-05-14 | Common Stock (15000) | Direct |
Footnotes
F1: 5 year vesting schedule, 20% vest each year starting 5/14/2003.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7